Centene faces declining enrollment and rising costs

Centene is experiencing declining Medicaid enrollment and rising costs, leading to reduced profit forecasts and a stock price drop. The company has significantly cut its 2025 profit guidance due to operational concerns, including surging medical costs and falling enrollment. Centene's financial performance lags competitors, with policy risks and increasing health issues posing further threats to its profitability.